Inactief instrument

Andere talen Willow Biosciences Inc Canadian Securities Exchange

Aandelen

CA97111B1076

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Willow Biosciences Provides Corporate Update and Signs New Partnered Program	26/06
Willow Biosciences Brief: Announced multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients	26/06
Willow Biosciences Brief: Expanding into the high growth biopesticide sector with addition of new partnered program	26/06
Willow Biosciences Brief: Announces its first patent being issued; Anticipates filing another five patents in 2024 primarily related to its steroid production platform	26/06
Willow Biosciences Brief: Anticipates revenue of over $1.0 million in Q2, and over $3.5 million for 2024 on existing programs	26/06
Willow Biosciences Brief: Providing Corporate Update and Signs New Partnered Program	26/06
WILLOW BIOSCIENCES PROVIDES CORPORATE UPDATE AND ANNOUNCES SIGNING OF A NEW PARTNERED PROGRAM	26/06
Willow Bioscience Announces 3 Million dollar Fundraising to Support Partnership with Laurus Labs	07/06
Willow Biosciences to Raise Up to $3 Million Via Brokered Private Placement; Shares Jumped 24% on Friday	03/06
Willow Biosciences Brief: Announcing Brokered Private Placement Offering To Raise Up To $3 Million	03/06
WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLION	03/06
Willow Biosciences Inc. announced that it expects to receive CAD 3 million in funding	03/06
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab	30/05
Willow Biosciences Brief: Announcing Multi-product Development and Licensing Partnership With Laurus Lab	30/05
Willow Biosciences Inc. Announces Multi-Product Development and Licensing Partnership with Laurus Labs	30/05
WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS	30/05
Willow Biosciences Brief: Reiterating its Expectations of at least doubling its full year 2024 revenues, As Reports Q1 Results	13/05
Willow Biosciences Inc. Provides Earnings Guidance for the Fiscal Year 2024	13/05
Willow Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
Willow Biosciences Narrows 2023 Loss YOY	01/04

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Willow Biosciences Inc Canadian Securities Exchange

Aandelen

CA97111B1076

Andere talen

Filters